Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 18 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the closure of a USFDA inspection at its oncology injectable plant in Ahmedabad. The inspection, which took place over a period of time, resulted in two observations, none of which were related to data integrity. The company plans to work closely with the USFDA to address these observations promptly.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases